Drugs that contain Roflumilast

1. List of Daliresp drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8431154 ASTRAZENECA Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
Feb, 2023

(13 days from now)

US9468598 ASTRAZENECA Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
Feb, 2023

(13 days from now)

US8618142 ASTRAZENECA Process for the preparation of roflumilast
Mar, 2024

(1 year, 1 month from now)

US8536206 ASTRAZENECA Process for the preparation of roflumilast
Mar, 2024

(1 year, 1 month from now)

US8604064 ASTRAZENECA Process for the preparation of roflumilast
Mar, 2024

(1 year, 1 month from now)

Market Authorisation Date: 28 February, 2011

Treatment: Treatment to reduce the risk of copd exacerbations in patients with severe copd associated with chronic bronchitis and a history of exacerbations

Dosage: TABLET;ORAL

How can I launch a generic of DALIRESP before it's patent expiration?
More Information on Dosage

2. List of Zoryve drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9907788 ARCUTIS Inhibition of crystal growth of roflumilast
Jun, 2037

(14 years from now)

US10940142 ARCUTIS Inhibition of crystal growth of roflumilast
Jun, 2037

(14 years from now)

US9884050 ARCUTIS Inhibition of crystal growth of roflumilast
Jun, 2037

(14 years from now)

US11129818 ARCUTIS Topical roflumilast formulation having improved delivery and plasma half life
Aug, 2037

(14 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Jul 29, 2025

Market Authorisation Date: 29 July, 2022

Treatment: Topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older. (1)

Dosage: CREAM;TOPICAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic